An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations (Q46798389)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 March 2017

Language	Label	Description	Also known as
English	An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations	scientific article published on 31 March 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

gynecologic oncology

1 reference

based on heuristic

inferred from title

author name string

Ritu Salani

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Namita Khanna

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Marina Frimer

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Robert E Bristow

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Lee-May Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

language of work or name

0 references

publication date

31 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

146

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

3-10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Cancer Statistics, 2017.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Cancer treatment and survivorship statistics, 2016.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Follow-up after primary therapy for endometrial cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Patterns and utility of routine surveillance in high grade endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Surveillance procedures for patients treated for endometrial cancer: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Recurrence patterns and surveillance for patients with early stage endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The utility and management of vaginal cytology after treatment for endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Post treatment surveillance of type II endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Surveillance of patients after initial treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The role of HE4 in ovarian cancer follow-up: a review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Correlation of CD44v6 expression with ovarian cancer progression and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Staging recurrent ovarian cancer with (18)FDG PET/CT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Borderline ovarian tumor in women aged ≥ 65 years: impact on recurrence and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Management of ovarian germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Ovarian stromal and germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Follow-up for women after treatment for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Recurrent cervical cancer: detection and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Cervical Cancer, Version 2.2015.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Surveillance procedures for patients for cervical carcinoma: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The role of PET scanning in the detection of recurrent cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Comparisons of patient and physician expectations for cancer survivorship care

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Primary care physicians' views of routine follow-up care of cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.03.022

7 January 2021

Identifiers

10.1016/J.YGYNO.2017.03.022

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28372871

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46798389&oldid=2132726709"